Affordable Access

Access to the full text

Genetic risk prediction of the plasma triglyceride response to independent supplementations with eicosapentaenoic and docosahexaenoic acids: the ComparED Study

  • Vallée Marcotte, Bastien1
  • Allaire, Janie1
  • Guénard, Frédéric1
  • de Toro-Martín, Juan1
  • Couture, Patrick1, 2
  • Lamarche, Benoît1
  • Vohl, Marie-Claude1
  • 1 Université Laval, 2440 Hochelaga Blvd., Quebec City, Quebec, Canada , Quebec City (Canada)
  • 2 CHU de Québec Research Center-Endocrinology and Nephrology, Quebec City, Quebec, Canada , Quebec City (Canada)
Published Article
Genes & Nutrition
Publication Date
Jun 15, 2020
DOI: 10.1186/s12263-020-00669-x
Springer Nature


BackgroundWe previously built a genetic risk score (GRS) highly predictive of the plasma triglyceride (TG) response to an omega-3 fatty acid (n-3 FA) supplementation from marine sources. The objective of the present study was to test the potential of this GRS to predict the plasma TG responsiveness to supplementation with either eicosapentaenoic (EPA) or docosahexaenoic (DHA) acids in the Comparing EPA to DHA (ComparED) Study.MethodsThe ComparED Study is a double-blind, controlled, crossover trial, with participants randomized to three supplemented phases of 10 weeks each: (1) 2.7 g/day of DHA, (2) 2.7 g/day of EPA, and (3) 3 g/day of corn oil (control), separated by 9-week washouts. The 31 SNPs used to build the previous GRS were genotyped in 122 participants of the ComparED Study using TaqMan technology. The GRS for each participant was computed by summing the number of rare alleles. Ordinal and binary logistic models, adjusted for age, sex, and body mass index, were used to calculate the ability of the GRS to predict TG responsiveness.ResultsThe GRS predicted TG responsiveness to EPA supplementation (p = 0.006), and a trend was observed for DHA supplementation (p = 0.08). The exclusion of participants with neutral TG responsiveness clarified the association patterns and the predictive capability of the GRS (EPA, p = 0.0003, DHA p = 0.01).ConclusionResults of the present study suggest that the constructed GRS is a good predictor of the plasma TG response to supplementation with either DHA or EPA.Trial, NCT01810003. The study protocol was registered on March 4, 2013.

Report this publication


Seen <100 times